SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.87-2.3%Dec 5 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (3969)6/3/2001 8:20:59 PM
From: Biomaven   of 52153
 
IJ,

I find it incredible that Venter would really state his intention to buy a publicly held chemistry company if he was really serious about doing so. There aren't that many chemistry companies around and so any rumors would serve to cause a run-up before an announcement and so decrease the attractiveness of any offer they made. It may indicate they are looking at privately held companies instead.

Building a chemistry company is tough - good medicinal chemists are apparently like gold. It's an area where many biotechs are apparently weak, except for a handful like VRTX, MLNM and NRGN.

Personally I don't understand why CRA wouldn't go the much easier Mab route first if they really want to be a products company.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News